Published in Eur J Neurosci on July 14, 2010
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol (2011) 10.82
Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65
The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci (2011) 1.54
Anti-NMDA Receptor Encephalitis in Psychiatry. Curr Psychiatry Rev (2011) 1.15
Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol (2015) 1.13
Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses. EMBO J (2014) 1.02
The Diagnosis and Treatment of Autoimmune Encephalitis. J Clin Neurol (2016) 0.92
Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. JAMA Neurol (2014) 0.89
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol (2012) 0.87
Paraneoplastic disorders. Continuum (Minneap Minn) (2015) 0.86
Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications. Schizophr Bull (2014) 0.84
The growing spectrum of antibody-associated inflammatory brain diseases in children. Neurol Neuroimmunol Neuroinflamm (2015) 0.84
The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms. Open Neurol J (2012) 0.82
Mechanisms of Autoantibody-Induced Pathology. Front Immunol (2017) 0.76
Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology. PLoS One (2016) 0.76
Molecular Pathogenesis of Anti-NMDAR Encephalitis. Biomed Res Int (2015) 0.76
Absence of NMDA receptor antibodies in patients with ovarian teratoma without encephalitis. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med (2008) 12.90
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron (1994) 11.44
Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature (1998) 10.50
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Guillain-Barré syndrome. Lancet (2005) 8.73
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain (2000) 7.95
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain (2004) 7.38
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell (1996) 6.96
The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol (2007) 6.91
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain (2002) 6.85
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature (2009) 6.81
Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron (2000) 6.22
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology (2004) 4.74
NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res (2000) 4.66
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
Paraneoplastic syndromes of the CNS. Lancet Neurol (2008) 4.62
Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science (1999) 4.56
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell (2006) 4.35
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med (2001) 4.35
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci (2009) 4.32
NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol (2006) 3.61
Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis (2006) 3.59
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med (2000) 3.57
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 3.11
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist (2005) 3.11
Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06
Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist (2007) 3.06
Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A (2006) 2.97
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain (2008) 2.91
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol (2009) 2.86
A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl Acad Sci U S A (2004) 2.84
Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol (2008) 2.80
Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol (1995) 2.79
Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology (2002) 2.68
Association between Campylobacter infection and Guillain-Barré syndrome. J Infect Dis (1997) 2.59
NMDA receptors, place cells and hippocampal spatial memory. Nat Rev Neurosci (2004) 2.53
Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry (2006) 2.52
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A (2006) 2.51
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron (2001) 2.51
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol (2008) 2.48
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci (2003) 2.43
Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron (1996) 2.42
Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med (2003) 2.40
Spatial memory dissociations in mice lacking GluR1. Nat Neurosci (2002) 2.39
Paraneoplastic limbic encephalitis in a teenage girl with an immature ovarian teratoma. Pediatr Radiol (2005) 2.34
Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain. Neuron (2004) 2.31
Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun (2005) 2.28
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27
Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol (2009) 2.25
Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain (2006) 2.25
Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med (2010) 2.24
Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit. Proc Natl Acad Sci U S A (1999) 2.23
Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology (2001) 2.18
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16
Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med (1978) 2.15
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology (2008) 2.13
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med (1977) 2.03
Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science (1994) 1.98
Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol (2001) 1.98
The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol (2004) 1.96
The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev (2005) 1.96
Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet (1995) 1.94
Myasthenia gravis: passive transfer from man to mouse. Science (1975) 1.90
Guillain-Barré syndrome. Lancet (1998) 1.89
Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc (1977) 1.85
Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell (1994) 1.82
Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1999) 1.81
Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci (2004) 1.78
Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr Top Med Chem (2006) 1.77
Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol (1994) 1.73
Excitatory-inhibitory balance and critical period plasticity in developing visual cortex. Prog Brain Res (2005) 1.72
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol (2003) 1.69
Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol (2010) 1.59
Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol Cell Neurosci (2001) 1.58
Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia. Front Mol Neurosci (2008) 1.58
Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med (2008) 1.54
Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol (2001) 1.54
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry (2007) 1.53
Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies. Eur J Neurol (2007) 1.51
Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory. Behav Neurosci (2007) 1.48
Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol (2006) 1.47
Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology (1998) 1.46
Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am (2008) 1.44
Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat Neurosci (1999) 1.43
Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol (2007) 1.41
Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol (1980) 1.35
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry (2002) 1.34
Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res (2001) 1.34
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol (2010) 7.97
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol (2005) 5.89
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr (2012) 4.12
Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol (2009) 3.97
The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis (2012) 3.63
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 3.40
Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol (2012) 3.20
Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist (2007) 3.06
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol (2011) 2.99
N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol (2012) 2.91
Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology (2012) 2.83
Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology (2013) 2.82
Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology (2011) 2.70
EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol (2006) 2.67
Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology (2011) 2.57
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell (2008) 2.55
Antibodies and neuronal autoimmune disorders of the CNS. J Neurol (2009) 2.40
Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol (2010) 2.36
Astrocytes regulate inhibitory synapse formation via Trk-mediated modulation of postsynaptic GABAA receptors. J Neurosci (2005) 2.32
Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology (2013) 2.32
Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol (2009) 2.25
Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures. N Engl J Med (2011) 2.21
Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. J Neurosci (2006) 2.17
Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol (2013) 2.12
Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol (2013) 2.10
Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol (2014) 2.07
Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol (2003) 2.05
Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry (2011) 2.01
Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology (2010) 1.98
Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr (2010) 1.91
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol (2012) 1.80
Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 1.73
Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol (2010) 1.72
Autoimmune encephalopathies. Ann N Y Acad Sci (2014) 1.65
Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol (2010) 1.59
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET. J Neurol Sci (2006) 1.57
The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci (2011) 1.54
Autoimmune encephalitis in children. J Child Neurol (2012) 1.53
Tumor blush: left ventricular cardiac hemangioma with supply from both the left anterior descending and circumflex arteries. J Invasive Cardiol (2012) 1.50
A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol (2013) 1.50
Young girl with psychosis, cognitive failure and seizures. Tidsskr Nor Laegeforen (2012) 1.47
Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Am J Psychiatry (2012) 1.46
Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol (2007) 1.41
Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses. J Neurosci (2004) 1.35
Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord (2010) 1.34
Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology (2011) 1.33
In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis (2010) 1.33
Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum (2011) 1.32
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. J Neurol (2011) 1.29
Paraneoplastic neurological syndromes. Curr Opin Neurol (2012) 1.29
Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol (2008) 1.29
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol (2007) 1.29
Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol (2011) 1.28
Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurol Clin Pract (2012) 1.25
Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology (2008) 1.23
Organelle positioning in muscles requires cooperation between two KASH proteins and microtubules. J Cell Biol (2012) 1.23
Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol (2012) 1.23
Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis. Mol Cell Neurosci (2009) 1.22
Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol (2011) 1.22
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology (2014) 1.19
Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry (2012) 1.17
Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics (2009) 1.17
Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry (2010) 1.16
Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol (2013) 1.15
Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol (2015) 1.13
Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol (2014) 1.13
Neuromuscular synaptogenesis in wild-type and mutant zebrafish. Dev Biol (2005) 1.12
Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol (2010) 1.11
Neurobeachin is essential for neuromuscular synaptic transmission. J Neurosci (2004) 1.08
Reduced gap junctional coupling leads to uncorrelated motor neuron firing and precocious neuromuscular synapse elimination. Proc Natl Acad Sci U S A (2007) 1.08
Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol (2013) 1.08
In vivo imaging of preferential motor axon outgrowth to and synaptogenesis at prepatterned acetylcholine receptor clusters in embryonic zebrafish skeletal muscle. J Neurosci (2006) 1.07
Inverse ocular bobbing in a patient with encephalitis associated with antibodies to the N-methyl-D-aspartate receptor. Arch Neurol (2008) 1.06
Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies. J Neurol (2010) 1.06
Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease. Nat Clin Pract Neurol (2006) 1.04
Activity-dependent elimination of neuromuscular synapses. J Neurocytol (2004) 1.04
Autoimmunity, seizures, and status epilepticus. Epilepsia (2013) 1.03